Cargando…
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis
With repeated positivity being an undiscovered and major concern, we aimed to evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. A systematic literature search was performed on 5 April 20...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146492/ https://www.ncbi.nlm.nih.gov/pubmed/33946311 http://dx.doi.org/10.3390/v13050809 |
_version_ | 1783697409900019712 |
---|---|
author | Dembrovszky, Fanni Váncsa, Szilárd Farkas, Nelli Erőss, Bálint Szakó, Lajos Teutsch, Brigitta Bunduc, Stefania Nagy, Rita Dohos, Dóra Kiss, Szabolcs Párniczky, Andrea Vinkó, Zsófia Péterfi, Zoltán Hegyi, Péter |
author_facet | Dembrovszky, Fanni Váncsa, Szilárd Farkas, Nelli Erőss, Bálint Szakó, Lajos Teutsch, Brigitta Bunduc, Stefania Nagy, Rita Dohos, Dóra Kiss, Szabolcs Párniczky, Andrea Vinkó, Zsófia Péterfi, Zoltán Hegyi, Péter |
author_sort | Dembrovszky, Fanni |
collection | PubMed |
description | With repeated positivity being an undiscovered and major concern, we aimed to evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. A systematic literature search was performed on 5 April 2021. Cohort studies with risk factors for repeated RSP or information about the immunoglobulin response (immunoglobulin M (IgM) and/or immunoglobulin G (IgG)) were included in this analysis. The main examined risk factors were severity of the initial infection, body mass index (BMI), length of hospitalization (LOH), age, and gender, for which we pooled mean differences and odds ratios (ORs). Thirty-four cohort studies (N = 9269) were included in our analysis. We found that increased RSP rate might be associated with IgG positivity; IgG presence was higher in RSP patients (OR: 1.72, CI: 0.87–3.41, p = 0.117). Among the examined risk factors, only mild initial disease course showed a significant association with RSP (OR: 0.3, CI: 0.14–0.67, p = 0.003). Age, male gender, BMI, LOH, and severity of the first episode do not seem to be linked with repeated positivity. However, further prospective follow-up studies focusing on this topic are required. |
format | Online Article Text |
id | pubmed-8146492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81464922021-05-26 Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis Dembrovszky, Fanni Váncsa, Szilárd Farkas, Nelli Erőss, Bálint Szakó, Lajos Teutsch, Brigitta Bunduc, Stefania Nagy, Rita Dohos, Dóra Kiss, Szabolcs Párniczky, Andrea Vinkó, Zsófia Péterfi, Zoltán Hegyi, Péter Viruses Review With repeated positivity being an undiscovered and major concern, we aimed to evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. A systematic literature search was performed on 5 April 2021. Cohort studies with risk factors for repeated RSP or information about the immunoglobulin response (immunoglobulin M (IgM) and/or immunoglobulin G (IgG)) were included in this analysis. The main examined risk factors were severity of the initial infection, body mass index (BMI), length of hospitalization (LOH), age, and gender, for which we pooled mean differences and odds ratios (ORs). Thirty-four cohort studies (N = 9269) were included in our analysis. We found that increased RSP rate might be associated with IgG positivity; IgG presence was higher in RSP patients (OR: 1.72, CI: 0.87–3.41, p = 0.117). Among the examined risk factors, only mild initial disease course showed a significant association with RSP (OR: 0.3, CI: 0.14–0.67, p = 0.003). Age, male gender, BMI, LOH, and severity of the first episode do not seem to be linked with repeated positivity. However, further prospective follow-up studies focusing on this topic are required. MDPI 2021-04-30 /pmc/articles/PMC8146492/ /pubmed/33946311 http://dx.doi.org/10.3390/v13050809 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dembrovszky, Fanni Váncsa, Szilárd Farkas, Nelli Erőss, Bálint Szakó, Lajos Teutsch, Brigitta Bunduc, Stefania Nagy, Rita Dohos, Dóra Kiss, Szabolcs Párniczky, Andrea Vinkó, Zsófia Péterfi, Zoltán Hegyi, Péter Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis |
title | Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis |
title_full | Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis |
title_fullStr | Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis |
title_short | Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis |
title_sort | immunoglobulin response and prognostic factors in repeated sars-cov-2 positive patients: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146492/ https://www.ncbi.nlm.nih.gov/pubmed/33946311 http://dx.doi.org/10.3390/v13050809 |
work_keys_str_mv | AT dembrovszkyfanni immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT vancsaszilard immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT farkasnelli immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT erossbalint immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT szakolajos immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT teutschbrigitta immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT bunducstefania immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT nagyrita immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT dohosdora immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT kissszabolcs immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT parniczkyandrea immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT vinkozsofia immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT peterfizoltan immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis AT hegyipeter immunoglobulinresponseandprognosticfactorsinrepeatedsarscov2positivepatientsasystematicreviewandmetaanalysis |